Bpifrance logo
Bpifrance

Health-Economic Benefit Assessment of Digital and Equipment-Based Medical Devices

Funds clinical evaluations of innovative CE-marked digital and equipment medical devices.

ClosedBpifranceFrance

Health-Economic Benefit Assessment of Digital and Equipment-Based Medical Devices is a Bpifrance grant that funds clinical evaluations of innovative CE-marked digital and equipment medical devices, evaluating medico-economic and clinical benefit through a multi-centre clinical evaluation. A single organisation responsible for developing and CE-marking the device submits a complete dossier -- a pro…

This call funds studies that evaluate the medico-economic and clinical benefit of two kinds of CE-marked medical devices: ones where the innovation is mainly digital or AI-based, and innovative equipment-type devices used by a healthcare professional in a hospital or lab. A proposal must show an economic advantage, a medical advantage, or both, against the current state of the art, through a multi-centre clinical evaluation.

CycleiHow often this grant runs - e.g. annually, on a rolling basis, or a one-off call.No fixed schedule
Next deadlineiThe next date applications are due. Rolling means you can apply any time.-
Decision timeiTypical time from the deadline to the funder's decision.-
Project durationiHow long the funded work is expected to run.12–48 months
Award typeiThe form of funding - grant, equity, loan, tax credit, etc.Grant
Match fundingiThe share of project costs you must cover yourself. 0% = fully funded.-
Funding pooliThe total budget available across all awards in this round.-

Sign up free to see the funding breakdown

Sign up free to see the industries in scope

Sign up free to see the full eligibility

Sign up free to see how to apply

Sign up free to see what you submit

Sign up free to see the timeline

Sign up free to see where teams trip up

Guides for this application

All guides →
European Commission logo
Scheduled

Equitable Cancer Care Economics and Outcomes

🇪🇺European Commission · European Union

Funds three €5–7M projects that make cancer control more equitable, effective and cost-aware for patients and families.

MedtechBiotech
€5M – €7MSep'27
European Commission logo
Scheduled

Prevention and management of chronic non-communicable diseases in children and young people

🇪🇺European Commission · European Union

Funds implementation research that helps children and young people prevent and manage chronic disease equitably.

MedtechBiotech
€3M – €4MApr'27
European Commission logo
Scheduled

Horizon Health: Bio-printing for Regenerative Medicine

🇪🇺European Commission · European Union

Funds €7–10M projects that advance living-cell bio-printing from laboratory proof toward regenerative medicine.

BiotechMedtech
€7M – €10MSep'27
European Commission logo
Scheduled

Horizon Health: Antibody Therapies for Emerging Viruses

🇪🇺European Commission · European Union

Funds €9–10M projects that turn monoclonal antibodies into prevention and treatment options for one emerging virus.

BiotechMedtech
€9M – €10MApr'27
European Commission logo
Scheduled

Innovative healthcare interventions for non-communicable diseases

🇪🇺European Commission · European Union

Funds €7–8M projects that validate innovative interventions for cardiovascular, metabolic, respiratory or kidney disease.

BiotechMedtech
€7M – €8MApr'27
European Commission logo
Scheduled

Horizon Health: Virtual Human Twins for Clinical Decision Support

🇪🇺European Commission · European Union

Funds €10–12M projects that make Virtual Human Twins useful for prevention, diagnosis and safer clinical decisions.

AIMedtech
€10M – €12MSep'27